From Combinations to Single-Molecule Polypharmacology—Cromolyn-Ibuprofen Conjugates for Alzheimer’s Disease

Despite Alzheimer’s disease (AD) incidence being projected to increase worldwide, the drugs currently on the market can only mitigate symptoms. Considering the failures of the classical paradigm “one target-one drug-one disease” in delivering effective medications for AD, polypharmacology appears to...

Descripción completa

Detalles Bibliográficos
Autores principales: Albertini, Claudia, Naldi, Marina, Petralla, Sabrina, Strocchi, Silvia, Grifoni, Daniela, Monti, Barbara, Bartolini, Manuela, Bolognesi, Maria Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923232/
https://www.ncbi.nlm.nih.gov/pubmed/33669839
http://dx.doi.org/10.3390/molecules26041112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923232/
https://www.ncbi.nlm.nih.gov/pubmed/33669839
http://dx.doi.org/10.3390/molecules26041112

Ejemplares similares